EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 109 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $558,530 | -30.6% | 28,731 | +1.3% | 0.00% | 0.0% |
| Q1 2023 | $804,913 | +4.9% | 28,372 | +8.0% | 0.00% | 0.0% |
| Q4 2022 | $767,550 | +3.2% | 26,259 | -6.7% | 0.00% | 0.0% |
| Q3 2022 | $744,000 | -0.1% | 28,150 | +68.0% | 0.00% | 0.0% |
| Q2 2022 | $745,000 | -14.6% | 16,757 | -4.9% | 0.00% | 0.0% |
| Q1 2022 | $872,000 | -8.0% | 17,613 | -5.4% | 0.00% | 0.0% |
| Q4 2021 | $948,000 | +2.6% | 18,625 | +12.4% | 0.00% | 0.0% |
| Q3 2021 | $924,000 | +203.9% | 16,568 | +119.4% | 0.00% | 0.0% |
| Q4 2018 | $304,000 | -76.3% | 7,551 | -64.8% | 0.00% | -66.7% |
| Q3 2017 | $1,281,000 | -35.6% | 21,472 | -14.8% | 0.00% | -40.0% |
| Q2 2017 | $1,989,000 | – | 25,213 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 113,737 | $3,227 | 0.98% |
| Smith, Graham & Co., Investment Advisors, LP | 236,883 | $6,720,371 | 0.82% |
| Capital Impact Advisors, LLC | 13,607 | $386,031 | 0.47% |
| TANG CAPITAL MANAGEMENT LLC | 80,000 | $2,269,600 | 0.34% |
| BRANDES INVESTMENT PARTNERS, LP | 545,050 | $15,463,069 | 0.33% |
| Watershed Asset Management, L.L.C. | 9,496 | $269,402 | 0.33% |
| Jackson Creek Investment Advisors LLC | 25,164 | $714 | 0.30% |
| SummerHaven Investment Management, LLC | 18,178 | $515,710 | 0.30% |
| Virtus Fund Advisers, LLC | 1,117 | $31,689 | 0.22% |
| Virtus Investment Advisers, Inc. | 7,308 | $207,328 | 0.14% |